Ryan H. Hsu

Ryan H. Hsu

Auto-generated profile, based on publicly available information

Ryan H. Hsu

Salk Institute for Biological Studies

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 June 2018 in Molecular Systems Biology
Verified
Journal Article
Open access
PDF file
OVOphelia S Venturelli
Ophelia S Venturelli
ACAlex V Carr
Alex V Carr
GFGarth Fisher
Garth Fisher
RHRyan H Hsu
Ryan H Hsu
RLRebecca Lau
Rebecca Lau
AAAdam P Arkin
Adam P Arkin
The ecological forces that govern the assembly and stability of the human gut microbiota remain unresolved. We developed a generalizable model‐guided framework to predict higher‐dimensional consortia from time‐resolved measurements of lower‐order assemblages. This method was employed to decipher microbial interactions in a diverse human gut microbiome synthetic community. We show that pairwise interactions are major drivers of multi‐species community dynamics, as opposed to higher‐order interactions. The inferred ecological network exhibits a high proportion of negative and frequent positive interactions. Ecological drivers and responsive recipient species were discovered in the network. Our model demonstrated that a prevalent positive and negative interaction topology enables robust coexistence by implementing a negative feedback loop that balances disparities in monospecies fitness levels. We show that negative interactions could generate history‐dependent responses of initial species proportions that frequently do not originate from bistability. Measurements of extracellular metabolites illuminated the metabolic capabilities of monospecies and potential molecular basis of microbial interactions. In sum, these methods defined the ecological roles of major human‐associated intestinal species and illuminated design principles of microbial communities.

29 August 2023 in Liver Transplantation
Verified
Journal Article
Closed access
KCKenneth Chow
Kenneth Chow
BIBrittney Ibrahim
Brittney Ibrahim
KRKabir Rahal
Kabir Rahal
RHRyan H. Hsu
Ryan H. Hsu
TTTeresa Tan
Teresa Tan
SSSammy Saab
Sammy Saab
An abstract is unavailable. This article is available as a PDF only.

13 October 2017 in bioRxiv
Verified
Preprint
Open access
PDF file
RHRyan H. Hsu
Ryan H. Hsu
DMDylan M. McCormick
Dylan M. McCormick
MSMitchell Lee J. Seitz
Mitchell Lee J. Seitz
LLLauren M. Lui
Lauren M. Lui
HRHarneet S. Rishi
Harneet S. Rishi
AAAdam P. Arkin
Adam P. Arkin
Our knowledge of the relationship between the gut microbiome and health has rapidly expanded in recent years. Diet has been shown to have causative effects on microbiome composition, which can have subsequent implications on health. Soylent 2.0 is a liquid meal replacement drink that satisfies nearly 20% of all recommended daily intakes per serving. This study aims to characterize the changes in gut microbiota composition resulting from a short-term Soylent diet. Fourteen participants were separated into two groups: 5 in the regular diet group and 9 in the Soylent diet group. The regular diet group maintained a diet closely resembling self-reported regular diets. The Soylent diet group underwent three dietary phases: A) a regular diet for 2 days, B) a Soylent-only diet (five servings of Soylent daily and water as needed) for 4 days, and C) a regular diet for 4 days. Daily logs self-reporting diet, Bristol stool ratings, and any abdominal discomfort were electronically submitted. Eight fecal samples per participant were collected using fecal sampling kits, which were subsequently sent to uBiome, Inc. for sample processing and V4 16S rDNA sequencing. Reads were clustered into operational taxonomic units (OTUs) and taxonomically identified against the GreenGenes 16S database. We find that an individual’s alpha-diversity is not significantly altered during a Soylent-only diet. In addition, principal coordinate analysis using the unweighted UniFrac distance metric shows samples cluster strongly by individual and not by dietary phase. Among Soylent dieters, we find a significant increase in the ratio of Bacteroidetes to Firmicutes abundance, which is associated with several positive health outcomes, including reduced risks of obesity and intestinal inflammation.

14 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
LBLukas C. Bachmann
Lukas C. Bachmann
RHRyan H. Hsu
Ryan H. Hsu
KHKip J. Hermann
Kip J. Hermann
CWClaire E. Williams
Claire E. Williams
RFRichard L. Farman
Richard L. Farman
SPSamuel L. Pfaff
Samuel L. Pfaff
Gene complementation is a powerful tool for genetic selection and protein functional studies but typically requires extensive screening for complementary components. Here we engineered a platform for gene complementation based on RNA end-joining (REJ) that precisely and efficiently splices separate RNA units into functional coding mRNAs. REJ is mediated by short structured modular RNA segments of ~250bp that: (a) promote RNA::RNA interaction, (b) coopt the intrinsic cell splicing machinery to facilitate RNA trans-splicing, (c) minimizes translation of protein fragments from un-spliced RNA segments, and (d) encodes scar-free protein. We demonstrate that REJ is a broadly applicable system that can reliably split nearly any gene into complementary segments regardless of protein structure. To enable the use of this system we provide a toolbox of reporters and a web-based design tool to facilitate vector design. Demonstrated REJ applications include genetic complementation, intersectional labeling of cell types, and efficient expression of large proteins.

16 September 2026 in bioRxiv
Verified
Preprint
Open access
PDF file
RHRyan H. Hsu
Ryan H. Hsu
CWClaire E. Williams
Claire E. Williams
GMGeraldine Maier
Geraldine Maier
MGMiriam Gullo
Miriam Gullo
KLKaren Lettieri
Karen Lettieri
SPSamuel L. Pfaff
Samuel L. Pfaff
Duchenne muscular dystrophy (DMD) is a fatal disorder caused by dystrophin mutations, leading to progressive muscle degeneration and cardiac failure. Although AAV-based DMD therapies with innovative designs to overcome the cargo limits of the virus are effective in animal models, these current systems may face clinical translation challenges related to efficiency, off-target effects, and immunogenicity. We developed a multi-vector RNA End Joining (REJ) system to split large genes into multiple co-delivered AAVs that engage the cell's intrinsic spliceosome to precisely reassemble RNA segments that encode very large scar-free proteins. We show the system is efficient and has negligible off-target interactions. In vivo, REJ vectors expressing the adenine base editor Abe8e, mini-dystrophin Dp253, or native full-length dystrophin Dp427 each prevented muscle degeneration. Machine-learning histopathology of more than 120,000 myofibers revealed robust reductions in nuclear infiltration, improved centronucleation, and normalized hypertrophy, supported by functional, transcriptomic, and behavioral analyses. These findings establish REJ as a clinically viable AAV-based strategy for DMD that enables expression of large therapeutic proteins while avoiding potentially antigenic bacterial protein- or DNA-recombinases.